A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis
Status:
Withdrawn
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This trial will be a double-blind, randomized, placebo-controlled, safety, tolerability and
efficacy trial of SAN007 (5% East Indian sandalwood oil in a cream formulation) treatment
regimen when administered daily for up to 28 days to patients from 3 months to 65 years of
age, with atopic dermatitis.